Moreover, and considering the analgesic properties of several antioxidant compounds [45,46], we hypothesize that the antioxidant and antiapoptotic actions of DADS and GYY4137 may also contribute to potentiating the analgesic activity of MOR and DOR agonists during neuropathic pain. The gene discussed is OPRM1; the disease is neuropathic pain.